D4381 is the CDT code for localized delivery of antimicrobial agents via a controlled release vehicle into diseased crevicular tissue, billed per tooth. The most common product is Arestin (minocycline microspheres). Placed directly into periodontal pockets after scaling and root planing.
Last updated June 2026 · Reviewed by the PracticeAlpha billing team
Get help with D4381 claims →Use D4381 when you place a controlled-release antimicrobial agent directly into a diseased periodontal pocket. The tooth must have active periodontal disease with a documented pocket depth of 4mm or greater. The code is billed per tooth, so a patient receiving Arestin at six teeth on the same date generates six D4381 line items.
Common clinical scenarios: Placing Arestin following scaling and root planing when pockets are 5mm or deeper. Treating localized sites that did not respond to initial SRP therapy at the 4 to 6 week re-evaluation. Adjunctive therapy at isolated deep pockets in a patient already on periodontal maintenance. Cases where systemic antibiotics are not appropriate but local antimicrobial therapy is clinically indicated.
Do NOT use D4381 for: Systemic antibiotic prescriptions (no CDT code applies to those). Topical rinses applied at home. Standard scaling and root planing procedures (use D4341 or D4342). Periodontal maintenance visits without active antimicrobial placement (use D4910). Prophylaxis in a patient without documented periodontal disease (use D1110).
Click any code to see the difference.
Controlled-release antimicrobial agent placed into a specific diseased pocket. Per tooth. Adjunctive to mechanical therapy. Targets residual bacteria at the site level.
Mechanical removal of calculus, plaque, and biofilm from root surfaces. Per quadrant when 4 or more teeth are involved. The primary treatment for periodontitis. D4381 is placed after or alongside D4341, not instead of it.
Billing tip: D4381 and D4341 can and frequently are billed on the same date. The antimicrobial is placed at the conclusion of the SRP procedure. Document both services separately with tooth-specific and quadrant-specific notes. Payers that cover D4381 at all usually require evidence of concurrent or recent SRP.
D4381 is one of the most inconsistently covered CDT codes in dentistry. Many plans explicitly exclude local drug delivery, categorizing it as investigational or non-covered. Before placing Arestin or any controlled-release agent, verify the patient's specific benefit. If the plan does not cover D4381, the patient needs to know the out-of-pocket cost before treatment, not after.
The code requires diseased crevicular tissue. That means charted pocket depths of 4mm or more with clinical signs of active disease. If the periodontal chart in the record shows healthy pocket depths at the treated tooth, the claim will be denied. Payers look for probing depths in the notes. A general statement that the patient has periodontal disease is not enough. Chart the specific tooth with the specific depth on the date of service.
Most plans that cover D4381 require it to be tied to scaling and root planing. If D4381 is billed without any SRP on the claim or in the recent treatment history, many payers will deny it as not medically necessary. The antimicrobial is an adjunct to mechanical therapy. Without evidence of the mechanical therapy, the adjunct lacks justification.
Plans that do cover D4381 typically impose a once-per-tooth limit within a 12 to 24 month window. If the patient received D4381 at tooth number 14 eleven months ago and you bill it again, expect a denial. Track treatment history by tooth number. Submitting a clinical narrative explaining why retreatment is warranted within the frequency window sometimes results in an override, but prevention is more reliable than appeal.
Chart each tooth treated under D4381 with a recorded pocket depth of 4mm or greater. The probing depth at the specific tooth on the date of service is the primary clinical justification. Without it, there is no defense for the claim.
The clinical note must include a periodontal diagnosis. Stage and grade the disease if possible. "Localized stage II periodontitis" is far more defensible than "perio patient." The diagnosis links the procedure to the clinical need.
Record the specific antimicrobial product placed (e.g., Arestin 1mg) and the exact tooth number for each D4381 unit billed. If you bill four units, four tooth numbers must appear in the record. This is non-negotiable for per-tooth codes.
Note that scaling and root planing was performed at the same visit or at a recent prior visit, and that the antimicrobial is adjunctive to that mechanical therapy. Include the SRP date if it was a separate visit. Payers want to see the clinical sequence.
A current periapical or bitewing radiograph documenting interproximal bone levels supports the periodontal diagnosis and helps justify D4381 for payers that require imaging with perio claims. Not all plans require it, but having it on file prevents delays during review.
D4381 claims getting denied or covered inconsistently? We handle the verification, documentation review, and follow-up so you get paid.
Learn about our billing servicesD4381 is the CDT code for localized delivery of antimicrobial agents via a controlled release vehicle into diseased periodontal pocket tissue, billed per tooth. Arestin (minocycline microspheres) is the most commonly billed product under this code.
D4381 is typically placed at the same visit as scaling and root planing (D4341 or D4342) or at a re-evaluation visit. Some plans require SRP to be billed on the same date. Others allow placement at a follow-up if the pocket has not responded to initial therapy. Check the specific plan before billing.
D4381 is billed per tooth, per visit. There is no fixed CDT frequency limit, but most insurance plans impose their own limitations, commonly allowing retreatment no more than once every 12 to 24 months per tooth. Always verify the patient's plan benefit limits before placing the agent.
Common denial reasons include the plan not covering local antimicrobials as a standalone benefit, missing proof of active periodontal disease, no record of SRP being performed, frequency limitation violations, and insufficient documentation of pocket depth at the treated site.
D4910 is periodontal maintenance, a recurring visit for patients who have completed active periodontal therapy. D4381 is the placement of a controlled-release antimicrobial agent into a specific diseased pocket. They can be billed on the same date if both are performed, as long as documentation supports each service separately.
Yes. D4381 and D4341 (or D4342) can be billed together on the same date when the antimicrobial is placed immediately following SRP. Document the specific tooth number, pocket depth, and product placed. Most plans that cover D4381 at all expect it to be tied to active SRP treatment.
Search all 206 CDT codes in our dental coding guide.